Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
Best abstract: Comprehensive epigenome-wide DANN methylation profiling in Inflammatory Bowel Disease
Source: Presentation - ECCO 2016 Amsterdam Congress - Scientific session 2: Application of genetic testing in understanding and managing IBD (Keywords: genetic, IBD,CD,UC,SNP, epigenetics, DNA methylation, gene expression, CD4+ T-cell, CD8+ T Cell, CD14+ Monocyte, RPS6KA2, TXK, miR21, WRAP73)
Authors: Nicholas Ventham
Best abstract: Deep remission in Crohns Disease does not prevent disease relapse after withdrawal of anti-TNF a therapy
Source: Presentation - ECCO 2015 Barcelona Congress - Scientific session 2: Pharmacokinetics in clinical practice (Keywords: adalimumab, infliximab, Crohn's disease, relapse, treatment discontinuation)
Authors: Martin Bortlik
Best abstract: Development and validation of diagnostic criteria for IBD-Unclassified (IBDU) in children: A multicentre longitudinal study from the Paediatric IBD Porto group of ESPGHAN
Source: Presentation - ECCO 2016 Amsterdam Congress - Scientific session 6: Bugs and drugs in IBD (Keywords: IBD, CD, UC, IBD unclassified, diagnostic criteria, colonic IBD)
Authors: L.B. Schwartz
Best abstract: Development of the Crohns Disease (CD) digestive damage score: The Lemann score
Source: Presentation - ECCO 2013 Vienna Congress - Scientific session 2: Preventing progression in IBD
Authors: Benjamin Pariente
Best abstract: Development of three practical indices for mucosal healing among patients with moderate to severe Crohn's Disease
Source: Presentation - ECCO'12 Barcelona Congress
Authors: Edouard Louis
Best abstract: Disease burden outweighs the impact of drug concentrations and antibodies to infliximab in primary non-response to infliximab in Crohns disease patients
Source: Presentation - ECCO 2015 Barcelona Congress - Scientific session 2: Pharmacokinetics in clinical practice (Keywords: anti-TNF, biologic treatment, CRP, CD, immunosuppressive agents, infliximab, trough levels)
Authors: Thomas Billiet
Best abstract: Drug-concentration versus symptom-driven dose adaptation of infliximab in patients with active Crohn’s Disease: A prospective, randomised, multicentre trial (Tailorix)
Source: Presentation - ECCO 2016 Amsterdam Congress - Scientific session 11: Right time, right drug, right strategy
Authors: Geert D'Haens
Best abstract: Early combined immunosuppression for the management of Crohn’s Disease: A community-based cluster randomized trial
Source: Presentation - ECCO 2014 Copenhagen Congress - Scientific session 2: Optimisation of therapy: Best abstract: Early combined immunosuppression for the management of Crohn’s Disease: A community-based cluster randomized trial (Keywords: adalimumab, AZA, clinical trials, CD, immunosuppressive agents, infliximab, methtrexate)
Authors: Brian G. Feagan
Best abstract: Early endoscopic, laboratory and clinical predictors of poor disease course in paediatric Ulcerative Colitis (UC)
Source: Presentation - ECCO 2014 Copenhagen Congress - Scientific session 6: Intestinal failure: Best abstract: Early endoscopic, laboratory and clinical predictors of poor disease course in paediatric Ulcerative Colitis (UC) (Keywords: 5-ASA, AZA, colectomy, complications, CRP, disease activity, disease outcome, endoscopic asessment, IBD, UC, immunosuppressive agents, infliximam, monitoring)
Authors: Dan Turner
Best abstract: Efficacy and safety of oral tofacitinib as induction therapy in patients with moderate to severe Ulcerative Colitis: Results from two phase 3 randomised controlled trials
Source: Presentation - ECCO 2016 Amsterdam Congress - Scientific session 7: ECCO Fellowships & Grants (Keywords: disease activity, disease outcome, mesalamine, mucosal immunology)
Authors: Geert D'Haens
Best abstract: Efficacy and safety of oral tofacitinib for induction therapy in patients with moderate to severe Crohn’s Disease: Results of a Phase 2b randomised placebo-controlled trial
Source: Presentation - ECCO 2016 Amsterdam Congress - Scientific session 9: What’s new on the Guidelines front? (Keywords: CD, immunosuppressive agents, trials)
Authors: Geert D'Haens
Best abstract: Efficacy and safety of oral tofacitinib for maintenance therapy in patients with moderate to severe Crohn’s Disease: Results of a Phase 2b randomised placebo-controlled trial
Source: Presentation - ECCO 2016 Amsterdam Congress - Scientific session 9: What’s new on the Guidelines front?
Authors: Julián Panés
Best abstract: Epigenetic control of colonic inflammation via the methyl-binding protein Mbd2
Source: Presentation - ECCO 2014 Copenhagen Congress - Scientific session 5: Fibrosis as a complication: Best abstract: Epigenetic control of colonic inflammation via the methyl-binding protein Mbd2 (Keywords: epigenetics, mucosal immunology)
Authors: Gareth-Rhys Jones
Best abstract: Escalation of medical therapy decreases need for repeat dilatation in Crohn‘s anastomatic strictures
Source: Presentation - ECCO 2016 Amsterdam Congress - Scientific session 10: Surgical and endoscopic FAQs in IBD (Keyword: anti-TNF, balloon dilation, biologic treatment, complications, disease activity, CD, ileocecal resection, immunosuppressive agents, postoperative)
Authors: Nik Sheng Ding
Best abstract: Evolution of corticosteroid use in Crohn’s Disease patients between 1991 and 2014: Results from the Dutch population-based IBDSL cohort
Source: Presentation - ECCO 2016 Amsterdam Congress - Scientific session 4: Viruses and IBD (Keywords: disease outcome, CD, corticosteroids, population-based cohort)
Authors: Steven Jeuring
Best abstract: Filgotinib, a selective JAK1 inhibitor, induces clinical remission in patients with moderate-to-severe Crohn’s Disease: Interim analysis from the phase 2 FITZROY study
Source: Presentation - ECCO 2016 Amsterdam Congress - Scientific session 7: ECCO Fellowships & Grants (Keywords: IBD, CD, trials)
Authors: Séverine Vermeire
Best abstract: Forty-year analysis of colonoscopic surveillance for Ulcerative Colitis reveals decreasing risk of interval and advanced cancer and reducing colectomy rate for dysplasia
Source: Presentation - ECCO 2015 Barcelona Congress - Scientific session 9: What’s new on the guideline front? (Keywords: colectomy, colorectal cancer surveillance, UC)
Authors: Ryan Choi Chang Ho
Best abstract: Gene expression profiling in CD8 T cells predicts disease course in Crohn
Source: Presentation - ECCO'11 Dublin Congress
Authors: James Lee
Best abstract: Gene expression profiling indicates similar molecular pathways are active in adult and paediatric Crohn’s Disease
Source: Presentation - ECCO 2016 Amsterdam Congress - Scientific session 2: Application of genetic testing in understanding and managing IBD (Keywords: adolescents, clinical trials, CD, expression profiles)
Authors: Aleksandar Stojmirovic
Best abstract: Gene-microbiome interactions underlying the onset and the clinical phenotypes of Inflammatory Bowel Disease
Source: Presentation - ECCO 2016 Amsterdam Congress - Scientific session 2: Application of genetic testing in understanding and managing IBD (Keywords: genetic, IBD, CD, UC, microbiota)
Authors: Floris Imhann